Rescape Innovation Ltd reposted this
It was an honour to be involved in the last night's event. The passion, dedication and knowledge flowed through the evening. Great to discuss the patient impact DR.VR is having and the research that is exploring it. Looking forward to seeing the exponential impact The Frontier Funders Club will deliver in the coming years.
What's the role of impact investment and innovation in cancer care, and how can we finance it? Total pleasure to chair this discussion last night and thank you to our panellists Joe Stringer, Umaima Malik Ahmad, Tej Panesar, Prof Richard Simcock and innovators Stephen Towe, Dr Antony Rix and Kevin Moss for being part of Macmillan Cancer Support's latest Green Room event to discuss how we revolutionise cancer care, as we launch Macmillan's new Frontier Funders Club. We discussed: The importance of putting COMPASSIONATE CARE at the heart of innovation. “Time right now is the most precious resource there is in the health service. So innovations that allow us to deliver this – the high quality promise of modern therapies but keeping it compassionate – are really essential” Professor Richard Simcock, Chief Medical Officer, Macmillan Cancer Support The critical role of PATIENT INVOLVEMENT in designing innovation: “The feedback of the Macmillan innovation community throughout that journey – in making small changes to sort of things like what colour the product should be, the shape of it, what doesn't feel like a hospital at home, what can I carry around and take out in front of my friends without feeling like, you know, I'm a patient. That's been that's been key to our journey” Umaima Ahmad, CEO, 52North (creators of Neutrocheck) And the importance of DESIGNING FOR EQUITY - so that we 'design out' inequalities rather than 'designing them in'. These are all core parts of MACMILLAN'S INNOVATION IMPACT INVESTMENT PORTFOLIO - identifying impact-led investment opportunities, ensuring the participation of people living with cancer in design, providing connections to clinicians, bringing test, challenge and routes to scale to innovation. “Sometimes now it's less about eureka moments, it's more investing in teams that understand their market have the commercial skills and the understanding and the appetite. The real challenge in this sector is go-to-market" Joe Stringer, venture capital investor & former Head of Healthtech, Octopus Ventures “If you roll forward 10 years and imagine that maybe Macmillan is sitting there with a massive exit, capital to recycle into more investing into the space, an expert team that's known both for its investing and nuance and capabilities, as well as its focus on impact. There is a template there to build something really powerful.” Tej Panesar, veteran life sciences and healthcare investor And we talked about the vital role of donors in making work like this possible – through the FRONTIER FUNDERS CLUB, our new philanthropic giving club for those who want to play a lead role in supporting ground-breaking cancer innovation. Please just get in touch if you’d like to know more.
